These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
214 related articles for article (PubMed ID: 29459985)
1. When Do α-Synucleinopathies Start? An Epidemiological Timeline: A Review. Savica R; Boeve BF; Mielke MM JAMA Neurol; 2018 Apr; 75(4):503-509. PubMed ID: 29459985 [TBL] [Abstract][Full Text] [Related]
2. Survival and Causes of Death Among People With Clinically Diagnosed Synucleinopathies With Parkinsonism: A Population-Based Study. Savica R; Grossardt BR; Bower JH; Ahlskog JE; Boeve BF; Graff-Radford J; Rocca WA; Mielke MM JAMA Neurol; 2017 Jul; 74(7):839-846. PubMed ID: 28505261 [TBL] [Abstract][Full Text] [Related]
3. ɑ-Synuclein strains and the variable pathologies of synucleinopathies. Peelaerts W; Baekelandt V J Neurochem; 2016 Oct; 139 Suppl 1():256-274. PubMed ID: 26924014 [TBL] [Abstract][Full Text] [Related]
4. Neuropathological and genetic correlates of survival and dementia onset in synucleinopathies: a retrospective analysis. Irwin DJ; Grossman M; Weintraub D; Hurtig HI; Duda JE; Xie SX; Lee EB; Van Deerlin VM; Lopez OL; Kofler JK; Nelson PT; Jicha GA; Woltjer R; Quinn JF; Kaye J; Leverenz JB; Tsuang D; Longfellow K; Yearout D; Kukull W; Keene CD; Montine TJ; Zabetian CP; Trojanowski JQ Lancet Neurol; 2017 Jan; 16(1):55-65. PubMed ID: 27979356 [TBL] [Abstract][Full Text] [Related]
5. Lifelong constipation in Parkinson's disease and other clinically defined alpha-synucleinopathies: A population-based study in Southeast Minnesota. Camerucci E; Mullan AF; Bower JH; Bharucha AE; Turcano P; Stang CD; Benarroch EE; Boeve BF; Ahlskog JE; Savica R Parkinsonism Relat Disord; 2023 Feb; 107():105244. PubMed ID: 36630736 [TBL] [Abstract][Full Text] [Related]
6. Delayed emergence of a parkinsonian disorder or dementia in 81% of older men initially diagnosed with idiopathic rapid eye movement sleep behavior disorder: a 16-year update on a previously reported series. Schenck CH; Boeve BF; Mahowald MW Sleep Med; 2013 Aug; 14(8):744-8. PubMed ID: 23347909 [TBL] [Abstract][Full Text] [Related]
7. Therapeutic approaches in Parkinson's disease and related disorders. Valera E; Masliah E J Neurochem; 2016 Oct; 139 Suppl 1(Suppl 1):346-352. PubMed ID: 26749150 [TBL] [Abstract][Full Text] [Related]
11. α-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study. Mollenhauer B; Locascio JJ; Schulz-Schaeffer W; Sixel-Döring F; Trenkwalder C; Schlossmacher MG Lancet Neurol; 2011 Mar; 10(3):230-40. PubMed ID: 21317042 [TBL] [Abstract][Full Text] [Related]
12. Filamentous alpha-synuclein inclusions link multiple system atrophy with Parkinson's disease and dementia with Lewy bodies. Spillantini MG; Crowther RA; Jakes R; Cairns NJ; Lantos PL; Goedert M Neurosci Lett; 1998 Jul; 251(3):205-8. PubMed ID: 9726379 [TBL] [Abstract][Full Text] [Related]
13. Brain alpha-synuclein accumulation in multiple system atrophy, Parkinson's disease and progressive supranuclear palsy: a comparative investigation. Tong J; Wong H; Guttman M; Ang LC; Forno LS; Shimadzu M; Rajput AH; Muenter MD; Kish SJ; Hornykiewicz O; Furukawa Y Brain; 2010 Jan; 133(Pt 1):172-88. PubMed ID: 19903734 [TBL] [Abstract][Full Text] [Related]
14. Infectious Agents as Potential Drivers of α-Synucleinopathies. Linard M; Ravier A; Mougué L; Grgurina I; Boutillier AL; Foubert-Samier A; Blanc F; Helmer C Mov Disord; 2022 Mar; 37(3):464-477. PubMed ID: 35040520 [TBL] [Abstract][Full Text] [Related]
15. A critical evaluation of current staging of alpha-synuclein pathology in Lewy body disorders. Jellinger KA Biochim Biophys Acta; 2009 Jul; 1792(7):730-40. PubMed ID: 18718530 [TBL] [Abstract][Full Text] [Related]
16. ɑ-Synuclein strains and seeding in Parkinson's disease, incidental Lewy body disease, dementia with Lewy bodies and multiple system atrophy: similarities and differences. Peelaerts W; Bousset L; Baekelandt V; Melki R Cell Tissue Res; 2018 Jul; 373(1):195-212. PubMed ID: 29704213 [TBL] [Abstract][Full Text] [Related]
17. α-Synuclein strains cause distinct synucleinopathies after local and systemic administration. Peelaerts W; Bousset L; Van der Perren A; Moskalyuk A; Pulizzi R; Giugliano M; Van den Haute C; Melki R; Baekelandt V Nature; 2015 Jun; 522(7556):340-4. PubMed ID: 26061766 [TBL] [Abstract][Full Text] [Related]